# Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia

> **NCT06982820** · NA · RECRUITING · sponsor: **GrayMatters Health Ltd.** · enrollment: 170 (estimated)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DEVICE:** Prism Training

## Key facts

- **NCT ID:** NCT06982820
- **Lead sponsor:** GrayMatters Health Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-25
- **Primary completion:** 2027-05-30
- **Final completion:** 2027-08-30
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06982820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06982820, "Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06982820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*